Takeda Pharmaceutical Company Limited
Substituted piperidine compound and use thereof

Last updated:

Abstract:

Provided is a substituted piperidine compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the DESCRIPTION, or a salt thereof has an orexin type 2 receptor agonist activity, and is useful as a prophylactic or therapeutic agent for narcolepsy. ##STR00001##

Status:
Grant
Type:

Utility

Filling date:

13 Dec 2019

Issue date:

5 Apr 2022